Guided Therapeutics ROIC
Was ist das ROIC von Guided Therapeutics?
ROIC von Guided Therapeutics, Inc. ist 253.77%
Was ist die Definition von ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Guided Therapeutics
Was macht Guided Therapeutics?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Unternehmen mit roic ähnlich Guided Therapeutics
- RCF Acquisition hat ROIC von 212.20%
- Panacea Acquisition hat ROIC von 226.13%
- Element Global hat ROIC von 233.70%
- Rightmove plc hat ROIC von 237.16%
- Idera Pharmaceuticals hat ROIC von 250.96%
- ShoulderUp Technology Acquisition hat ROIC von 253.24%
- Guided Therapeutics hat ROIC von 253.77%
- EVe Mobility Acquisition Corp hat ROIC von 272.67%
- LF Capital Acquisition hat ROIC von 272.75%
- SOAR Technology Acquisition hat ROIC von 285.99%
- Communications Synergy Technologies hat ROIC von 289.77%
- Gujarat Poly Electronics hat ROIC von 302.34%
- SCVX Corp hat ROIC von 312.20%